Evidence map

ReviewTherapeutic advances in endocrinology and metabolism2024

Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor.

Lirong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39071115